Roche to invest $750M in Oregon manufacturing expansion
Roche's subsidiary Genentech announced a $750 million investment to double the capacity of its production facility in Oregon. The expansion aims to increase manufacturing output for its pharmaceutical products. This move underscores Roche's commitment to strengthening its U.S. manufacturing footprint.
Related stories
Genentech commits $750M to Oregon facility; Bavarian Nordic pushes back Lyme vaccine study · Drug development
AstraZeneca halts late-stage lung cancer trial; U.S. drug prices decline · Cancer research
Regeneron secures approval for ultra-rare bone disorder drug · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more.” Browse more stories.